Abry Partners Recapitalizes SERMO
February 7, 2019
SERMO, the global social platform and healthcare market research company for physicians, completed a recapitalization with Boston-based private equity firm Abry Partners. The investment will fund SERMO's growth initiatives, including a new member experience, expanded automation and tooling, and broader physician membership and product launches.
- Buyers
- Abry Partners
- Targets
- SERMO
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Abry Partners Recapitalizes Anju Software
February 28, 2019
Software
Abry Partners, a Boston-based private equity firm, completed a recapitalization of Phoenix-based Anju Software to provide capital for product enhancement and global expansion. Anju Software is a provider of integrated software and data solutions for the life sciences industry and will partner with Abry to accelerate growth and pursue market leadership.
-
Abry Partners Makes Significant Growth Investment in TeraSky
January 26, 2023
IT Services
Boston-based private equity firm Abry Partners has made a significant growth investment in TeraSky, an Israel-based multi-cloud, cloud-native and managed services provider. The capital will help deepen TeraSky's Israel presence and accelerate its expansion across the United States and Europe.
-
Abry Partners Recapitalizes GreenPages Technology Solutions
December 11, 2020
IT Services
Boston-based private equity firm Abry Partners completed a recapitalization of GreenPages Technology Solutions, a hybrid cloud services provider and systems integrator. The recapitalization will provide capital to accelerate GreenPages’ organic growth, support M&A activity and expand its go-to-market for cloud, security, and managed IT services.
-
Abry Partners Recapitalizes Benefit Recovery Group
October 16, 2020
Healthcare Services
Abry Partners made a recapitalization investment in Benefit Recovery Group (BRG), a Memphis-based tech-enabled payor services provider that specializes in healthcare subrogation and compensation recovery. The partnership will support BRG's sales investment and product development to accelerate growth; Abry partner T.J. Rose will join BRG's board.
-
Abry Partners Makes Significant Growth Investment in Options
January 7, 2020
IT Services
Abry Partners, a Boston-based private equity firm, has made a significant growth investment in Options, a London-headquartered provider of cloud-enabled managed IT services to the global capital markets. The deal will fund Options’ accelerated growth strategy, strategic M&A, further investment in its technology platform and expansion into key financial centers globally; terms were not disclosed.
-
SERB Pharmaceuticals Acquires Y-mAbs Therapeutics
September 16, 2025
Biotechnology
SERB Pharmaceuticals completed its acquisition of Y-mAbs Therapeutics following a tender offer and statutory merger, making Y-mAbs a wholly owned subsidiary and delisting it from Nasdaq. The deal adds Y-mAbs' antibody-based oncology assets — including Danyelza (naxitamab-gqgk) — to SERB's rare disease and rare oncology portfolio to expand its commercial capabilities in pediatric and rare cancers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.